RCT | Bedaquiline–Pretomanid–Linezolid regimens for drug-resistant tuberculosis.
2 Sep, 2022 | 13:16h | UTCBedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Three drug regimen with Linezolid 600 mg tied to better outcomes in drug-resistant TB – Medical Dialogues